Q1 2024 13F Holders as of 3/31/2024
-
Type / Class
-
Equity / COMMON STOCK
-
Shares outstanding
-
159M
-
Number of holders
-
355
-
Total 13F shares, excl. options
-
141M
-
Shares change
-
-1.44M
-
Total reported value, excl. options
-
$6.1B
-
Value change
-
-$80.6M
-
Put/Call ratio
-
0.54
-
Number of buys
-
166
-
Number of sells
-
-174
-
Price
-
$43.35
Significant Holders of IONIS PHARMACEUTICALS INC - COMMON STOCK (IONS) as of Q1 2024
431 filings reported holding IONS - IONIS PHARMACEUTICALS INC - COMMON STOCK as of Q1 2024.
IONIS PHARMACEUTICALS INC - COMMON STOCK (IONS) has 355 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 141M shares
of 159M outstanding shares and own 88.7% of the company stock.
Largest 10 shareholders include FMR LLC (21.9M shares), VANGUARD GROUP INC (13.4M shares), T. Rowe Price Investment Management, Inc. (13.3M shares), BlackRock Inc. (9.77M shares), Bellevue Group AG (8.3M shares), WELLINGTON MANAGEMENT GROUP LLP (5.7M shares), Clearbridge Investments, LLC (4.47M shares), STATE STREET CORP (4.16M shares), PICTET ASSET MANAGEMENT Holding SA (3.74M shares), and PRICE T ROWE ASSOCIATES INC /MD/ (3.52M shares).
This table shows the top 355 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.